Zhibo Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhibo Yang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Bijun Zeng
Hunan University of Chinese Medicine, Changsha, 410208, Hunan, China
8 shared publicationsChang Wang
Department of Dermatology, The Second Affiliated Hospital, The Domestic First-Class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine, Changsha, 410005, Hunan, China
7 shared publicationsYujin Zhang
Department of Dermatology, The Second Affiliated Hospital, The Domestic First-Class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine, Changsha, 410005, Hunan, China
7 shared publicationsHaizhen Wang
Department of Dermatology, The Second Affiliated Hospital, The Domestic First-Class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine, Changsha, 410005, Hunan, China.
5 shared publications- Bijun Zeng
Department of Dermatology, The Second Hospital of Hunan University of Chinese Medicine, The Domestic First-class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine, Changsha, China
3 shared publications - Chang Wang
Department of Dermatology, The Second Affiliated Hospital, The Domestic First-class Discipline Construction Project of Chinese Medicine of Hunan University of Chinese Medicine, Changsha, Hunan 410005, China
3 shared publications
Latest Publications
- 26 March 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (2)
Dendrobium officinale polysaccharides alleviate atopic dermatitis in vivo and in vitro through inhibition of inflammation and mitochondrial dysfunction
Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by immune dysregulation and oxidative stress. Current therapies, such as corticosteroids, have side effects, necessitating new treatments. This study investigates the therapeutic effects of Dendrobium officinale polysaccharides (DOP) on AD, specifically focusing on their role in modulating inflammation and mitochondrial dysfunction. An AD-like model was induced in BALB/c mice, while HaCaT keratinocytes stimulated with TNF-α/IFN-γ served as an in vitro model. In mice, DOP significantly alleviated AD symptoms, reduced inflammatory cytokines (IL-1β, IL-6) and oxidative stress markers (MDA, NO), and restored antioxidant enzyme levels (GSH, SOD, CAT). In HaCaT cells, DOP ameliorated mitochondrial dysfunction, evident by increased mitochondrial membrane potential, cellular ATP content, and normalized mitochondrial dynamics (restoring MFN1/MFN2 and reducing DRP1). Furthermore, DOP suppressed NF-κB activation both in vivo and in vitro. These findings suggest that DOP alleviates AD by reducing inflammation and oxidative stress while preserving mitochondrial homeostasis. The mechanism appears associated with NF-κB inhibition, though this link is correlational and requires further direct validation.
- 26 March 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (2)
Dendrobium officinale polysaccharides alleviate atopic dermatitis in vivo and in vitro through inhibition of inflammation and mitochondrial dysfunction
Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by immune dysregulation and oxidative stress. Current therapies, such as corticosteroids, have side effects, necessitating new treatments. This study investigates the therapeutic effects of Dendrobium officinale polysaccharides (DOP) on AD, specifically focusing on their role in modulating inflammation and mitochondrial dysfunction. An AD-like model was induced in BALB/c mice, while HaCaT keratinocytes stimulated with TNF-α/IFN-γ served as an in vitro model. In mice, DOP significantly alleviated AD symptoms, reduced inflammatory cytokines (IL-1β, IL-6) and oxidative stress markers (MDA, NO), and restored antioxidant enzyme levels (GSH, SOD, CAT). In HaCaT cells, DOP ameliorated mitochondrial dysfunction, evident by increased mitochondrial membrane potential, cellular ATP content, and normalized mitochondrial dynamics (restoring MFN1/MFN2 and reducing DRP1). Furthermore, DOP suppressed NF-κB activation both in vivo and in vitro. These findings suggest that DOP alleviates AD by reducing inflammation and oxidative stress while preserving mitochondrial homeostasis. The mechanism appears associated with NF-κB inhibition, though this link is correlational and requires further direct validation.
- 21 March 2024
- Published by Elsevier in Advances in Medical Sciences
- Vol. 69 (1) , 167-175
Dendrobium officinale Polysaccharide (DOP) inhibits cell hyperproliferation, inflammation and oxidative stress to improve keratinocyte psoriasis-like state
- 21 March 2024
- Published by Elsevier in Advances in Medical Sciences
- Vol. 69 (1) , 167-175
Dendrobium officinale Polysaccharide (DOP) inhibits cell hyperproliferation, inflammation and oxidative stress to improve keratinocyte psoriasis-like state
- Open Access
- 7 January 2024
- Published by Wiley in Skin Research and Technology
- Vol. 30 (1) , e13543
Dendrobium polysaccharide (DOP) ameliorates the LL‐37‐induced rosacea by inhibiting NF‐κB activation in a mouse model
Background: Rosacea, a common chronic inflammatory skin disease worldwide, is currently incurable with complex pathogenesis. Dendrobium polysaccharide (DOP) may exert therapeutic effects on rosacea via acting on the NF‐κB‐related inflammatory and oxidative processes.Materials and methods: In this study, an LL‐37‐induced rosacea‐like mouse model was established. HE staining was used to assess the skin lesions, erythema severity scores, pathological symptoms, and inflammatory cell numbers of mice in each group. The inflammation level was quantitatively analyzed using enzyme‐linked immunosorbent assay (ELISA) and reverse transcription‐quantitative real‐time polymerase chain reaction (RT‐qPCR). The expression levels of TLR4 and p‐NF‐κB were finally detected.Results: DOP improved skin pathological symptoms of rosacea mice. DOP also alleviated the inflammation of rosacea mice. Moreover, the TLR4/NF‐κB pathway was observed to be inhibited in the skin of mice after DOP application. These findings evidenced the anti‐inflammatory effects of DOP on the LL‐37‐induced rosacea mouse model. DOP could inhibit NF‐κB activation, suppress neutrophil infiltration, and reduce pro‐inflammatory cytokines production, which may be the reason for DOP protecting against rosacea.Conclusion: This study may propose an active candidate with great potential for rosacea drug development and lay a solid experimental foundation for promoting DOP application in rosacea therapy.
- 7 January 2024
- Published by Wiley in Skin Research and Technology
- Vol. 30 (1) , e13543
Open AccessDendrobium polysaccharide (DOP) ameliorates the LL‐37‐induced rosacea by inhibiting NF‐κB activation in a mouse model
Background: Rosacea, a common chronic inflammatory skin disease worldwide, is currently incurable with complex pathogenesis. Dendrobium polysaccharide (DOP) may exert therapeutic effects on rosacea via acting on the NF‐κB‐related inflammatory and oxidative processes.Materials and methods: In this study, an LL‐37‐induced rosacea‐like mouse model was established. HE staining was used to assess the skin lesions, erythema severity scores, pathological symptoms, and inflammatory cell numbers of mice in each group. The inflammation level was quantitatively analyzed using enzyme‐linked immunosorbent assay (ELISA) and reverse transcription‐quantitative real‐time polymerase chain reaction (RT‐qPCR). The expression levels of TLR4 and p‐NF‐κB were finally detected.Results: DOP improved skin pathological symptoms of rosacea mice. DOP also alleviated the inflammation of rosacea mice. Moreover, the TLR4/NF‐κB pathway was observed to be inhibited in the skin of mice after DOP application. These findings evidenced the anti‐inflammatory effects of DOP on the LL‐37‐induced rosacea mouse model. DOP could inhibit NF‐κB activation, suppress neutrophil infiltration, and reduce pro‐inflammatory cytokines production, which may be the reason for DOP protecting against rosacea.Conclusion: This study may propose an active candidate with great potential for rosacea drug development and lay a solid experimental foundation for promoting DOP application in rosacea therapy.
- 5 December 2022
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 47 (2) , 833-841
Dendrobium officinale Polysaccharide (DOP) Promotes Hair Regrowth in Testosterone-Induced Bald Mice
Background Androgenetic alopecia can affect up to 70% of males and 40% of females; however, certain therapeutic medications offer partial and transitory improvement but with major side effects. Dendrobium officinale polysaccharide (DOP) has been reported to improve androgen-related hair loss in mice, but the molecular mechanism remains unclear. Objectives To explore the effects of DOP on androgenetic alopecia. Methods In this study, testosterone was subcutaneously administered to shave dorsa skin of mice to establish androgenetic alopecia; the effects of DOP in androgenetic alopecia were explored by DOP administration. Results Testosterone treatment extended the time of skin growing dark and hair growing, decreased the mean numbers of follicles in skin tissues, decreased β-catenin and cyclin D1 levels, and elevated testosterone, DHT (dihydrotestosterone), and 5α-reductase levels. In contrast, DOP administration shortened skin growing dark and hair growing times, promoted follicle cell proliferation, increased follicle numbers, increased β-catenin and cyclin D1 levels, and decreased testosterone, DHT, and 5α-reductase levels. Conclusion DOP application significantly improved testosterone-induced hair follicle miniaturization and hair loss, possibly through affecting the Wnt signaling and hair follicle stem cell functions. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 5 December 2022
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 47 (2) , 833-841
Dendrobium officinale Polysaccharide (DOP) Promotes Hair Regrowth in Testosterone-Induced Bald Mice
Background Androgenetic alopecia can affect up to 70% of males and 40% of females; however, certain therapeutic medications offer partial and transitory improvement but with major side effects. Dendrobium officinale polysaccharide (DOP) has been reported to improve androgen-related hair loss in mice, but the molecular mechanism remains unclear. Objectives To explore the effects of DOP on androgenetic alopecia. Methods In this study, testosterone was subcutaneously administered to shave dorsa skin of mice to establish androgenetic alopecia; the effects of DOP in androgenetic alopecia were explored by DOP administration. Results Testosterone treatment extended the time of skin growing dark and hair growing, decreased the mean numbers of follicles in skin tissues, decreased β-catenin and cyclin D1 levels, and elevated testosterone, DHT (dihydrotestosterone), and 5α-reductase levels. In contrast, DOP administration shortened skin growing dark and hair growing times, promoted follicle cell proliferation, increased follicle numbers, increased β-catenin and cyclin D1 levels, and decreased testosterone, DHT, and 5α-reductase levels. Conclusion DOP application significantly improved testosterone-induced hair follicle miniaturization and hair loss, possibly through affecting the Wnt signaling and hair follicle stem cell functions. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 1 October 2021
- Published by Elsevier in Tissue and Cell
- Vol. 72, 101548
miR-506-3p regulates TGF- 1 and affects dermal fibroblast proliferation, migration and collagen formation after thermal injury
- 1 October 2021
- Published by Elsevier in Tissue and Cell
- Vol. 72, 101548
miR-506-3p regulates TGF- 1 and affects dermal fibroblast proliferation, migration and collagen formation after thermal injury
- Open Access
- 16 July 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-8
Kochia scoparia Saponin Momordin Ic Modulates HaCaT Cell Proliferation and Apoptosis via the Wnt/β-Catenin Pathway
Psoriasis is a chronic, recurrent, immunoinflammatory disease. For a long period, Traditional Chinese Medicine (TCM) is considered a reliable alternative therapy for patients with psoriasis. Fructus Kochiae (or Kochia scoparia) and its principle saponin, Momordin Ic, have been reported to protect against inflammation. Herein, we demonstrated that Momordin Ic could inhibit HaCaT cell proliferation and enhance cell apoptosis. In the meantime, Momordin Ic alters Wnt/β-catenin pathway activation by affecting β-catenin nuclear distribution. The Wnt/β-catenin signaling activator LiCl partially reversed the effects of Momordin Ic on HaCaT phenotypes and the Wnt/β-catenin pathway factors. Altogether, we demonstrate the inhibitory effects of Momordin Ic, one of the major saponin constituents of Fructus Kochiae, on HaCaT cell proliferation and Momordin Ic-induced alteration within the Wnt/β-catenin pathway. Momordin Ic might act on HaCaT cells by modulating the Wnt/β-catenin pathway.
- 16 July 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-8
Open AccessKochia scoparia Saponin Momordin Ic Modulates HaCaT Cell Proliferation and Apoptosis via the Wnt/β-Catenin Pathway
Psoriasis is a chronic, recurrent, immunoinflammatory disease. For a long period, Traditional Chinese Medicine (TCM) is considered a reliable alternative therapy for patients with psoriasis. Fructus Kochiae (or Kochia scoparia) and its principle saponin, Momordin Ic, have been reported to protect against inflammation. Herein, we demonstrated that Momordin Ic could inhibit HaCaT cell proliferation and enhance cell apoptosis. In the meantime, Momordin Ic alters Wnt/β-catenin pathway activation by affecting β-catenin nuclear distribution. The Wnt/β-catenin signaling activator LiCl partially reversed the effects of Momordin Ic on HaCaT phenotypes and the Wnt/β-catenin pathway factors. Altogether, we demonstrate the inhibitory effects of Momordin Ic, one of the major saponin constituents of Fructus Kochiae, on HaCaT cell proliferation and Momordin Ic-induced alteration within the Wnt/β-catenin pathway. Momordin Ic might act on HaCaT cells by modulating the Wnt/β-catenin pathway.
- 28 June 2020
- Published by Taylor & Francis in Cell Cycle
- Vol. 19 (15) , 1928-1940
miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ
Psoriasis is an immune-mediated chronic inflammatory skin disease. Keratinocyte hyperproliferation has been regarded as a significant event in psoriasis pathogenesis. Considering the vital role of miRNA-mediated mRNA repression in psoriasis pathogenesis, in the present study, we attempted to investigate the mechanism of keratinocyte overproliferation from the point of miRNA-mRNA regulation. Both online microarray expression profiles and experimental results indicated that the expression of LXR-α and PPAR-γ was downregulated in psoriasis lesion skin. LXR-α or PPAR-γ overexpression alone was sufficient to inhibit keratinocyte proliferation, decrease KRT5 and KRT14 protein levels and increase KRT1 and KRT10 protein levels. miR-203 negatively regulated LXR-α and PPAR-γ expression through direct targeting. miR-203 inhibition exerted the opposite effects to LXR-α or PPAR-γ overexpression on HaCaT cells. More importantly, LXR-α or PPAR-γ overexpression could markedly remarkably attenuate the effects of miR-203 overexpression in keratinocytes, indicating that miR-203 promotes keratinocyte proliferation by targeting LXR-α and PPAR-γ. In conclusion, the miR-203-LXR-α/PPAR-γ axis modulates the proliferation of keratinocytes and might be a novel target for psoriasis treatment, which needs further in vivo investigation.
- 28 June 2020
- Published by Taylor & Francis in Cell Cycle
- Vol. 19 (15) , 1928-1940
miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ
Psoriasis is an immune-mediated chronic inflammatory skin disease. Keratinocyte hyperproliferation has been regarded as a significant event in psoriasis pathogenesis. Considering the vital role of miRNA-mediated mRNA repression in psoriasis pathogenesis, in the present study, we attempted to investigate the mechanism of keratinocyte overproliferation from the point of miRNA-mRNA regulation. Both online microarray expression profiles and experimental results indicated that the expression of LXR-α and PPAR-γ was downregulated in psoriasis lesion skin. LXR-α or PPAR-γ overexpression alone was sufficient to inhibit keratinocyte proliferation, decrease KRT5 and KRT14 protein levels and increase KRT1 and KRT10 protein levels. miR-203 negatively regulated LXR-α and PPAR-γ expression through direct targeting. miR-203 inhibition exerted the opposite effects to LXR-α or PPAR-γ overexpression on HaCaT cells. More importantly, LXR-α or PPAR-γ overexpression could markedly remarkably attenuate the effects of miR-203 overexpression in keratinocytes, indicating that miR-203 promotes keratinocyte proliferation by targeting LXR-α and PPAR-γ. In conclusion, the miR-203-LXR-α/PPAR-γ axis modulates the proliferation of keratinocytes and might be a novel target for psoriasis treatment, which needs further in vivo investigation.
- 12 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (2) , 368-379
CTNNBIP1 modulates keratinocyte proliferation through promoting the transcription of β‐catenin/TCF complex downstream genes
Background: During psoriasis initiation and development, deregulations in signalling pathways and gene expression are observed.Methods: Herein, we downloaded seven sets of microarray mRNA expression profiles showing differentially expressed genes in psoriasis lesion skin and non‐lesion skin tissues and three sets of RNA‐seq data and analysed these online data attempting to screen for crucial genes related to keratinocyte proliferation and psoriasis development. The expression of CTNNBIP1 in psoriasis patients and IMQ mouse model skin tissues were examined by RT‐PCR, immunoblotting and IHC. The functions of CTNNBIP1 on HaCaT cell proliferation, apoptosis and β‐catenin/TCF complex were measured by MTT, EdU, flow cytometry, IF, luciferase assays and immunoblotting.Results: The expression of catenin beta interacting protein 1 (CTNNBIP1) was remarkably downregulated within psoriasis lesion skin tissue samples compared to that within non‐lesion skin tissues based on both online data and experimental results. In response to a period of different therapies, respectively, CTNNBIP1 expression could be rescued in lesion skin tissues. Within IMQ‐induced psoriasis‐like dermatitis in mice, CTNNBIP1 silence further aggravated psoriatic phenotypes. In human immortalized keratinocytes, HaCaT cells, CTNNBIP1 silence significantly inhibited cell apoptosis and promoted cell proliferation. Regarding the molecular mechanism, CTNNBIP1 silence in HaCaT cells promoted β‐catenin nucleus translocation, enhanced the transcriptional activity of TCF4 and increased β‐catenin/TCF complex downstream c‐Myc and cyclin D1 proteins, and also increased the expression of cell proliferation marker ki‐67. In contrast to CTNNBIP1, the expression of c‐Myc and cyclin D1 showed to be dramatically upregulated within psoriasis lesion tissue samples than that within non‐lesion tissue samples. Within tissues, c‐Myc and cyclin D1 showed to be negatively correlated with CTNNBIP1, respectively.Conclusions: We identify CTNNBIP1 as an abnormally downregulated gene in psoriasis. CTNNBIP1 silence significantly disturbs the proliferation of keratinocytes through promoting the transcription of β‐catenin/TCF complex downstream genes.
- 12 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (2) , 368-379
CTNNBIP1 modulates keratinocyte proliferation through promoting the transcription of β‐catenin/TCF complex downstream genes
Background: During psoriasis initiation and development, deregulations in signalling pathways and gene expression are observed.Methods: Herein, we downloaded seven sets of microarray mRNA expression profiles showing differentially expressed genes in psoriasis lesion skin and non‐lesion skin tissues and three sets of RNA‐seq data and analysed these online data attempting to screen for crucial genes related to keratinocyte proliferation and psoriasis development. The expression of CTNNBIP1 in psoriasis patients and IMQ mouse model skin tissues were examined by RT‐PCR, immunoblotting and IHC. The functions of CTNNBIP1 on HaCaT cell proliferation, apoptosis and β‐catenin/TCF complex were measured by MTT, EdU, flow cytometry, IF, luciferase assays and immunoblotting.Results: The expression of catenin beta interacting protein 1 (CTNNBIP1) was remarkably downregulated within psoriasis lesion skin tissue samples compared to that within non‐lesion skin tissues based on both online data and experimental results. In response to a period of different therapies, respectively, CTNNBIP1 expression could be rescued in lesion skin tissues. Within IMQ‐induced psoriasis‐like dermatitis in mice, CTNNBIP1 silence further aggravated psoriatic phenotypes. In human immortalized keratinocytes, HaCaT cells, CTNNBIP1 silence significantly inhibited cell apoptosis and promoted cell proliferation. Regarding the molecular mechanism, CTNNBIP1 silence in HaCaT cells promoted β‐catenin nucleus translocation, enhanced the transcriptional activity of TCF4 and increased β‐catenin/TCF complex downstream c‐Myc and cyclin D1 proteins, and also increased the expression of cell proliferation marker ki‐67. In contrast to CTNNBIP1, the expression of c‐Myc and cyclin D1 showed to be dramatically upregulated within psoriasis lesion tissue samples than that within non‐lesion tissue samples. Within tissues, c‐Myc and cyclin D1 showed to be negatively correlated with CTNNBIP1, respectively.Conclusions: We identify CTNNBIP1 as an abnormally downregulated gene in psoriasis. CTNNBIP1 silence significantly disturbs the proliferation of keratinocytes through promoting the transcription of β‐catenin/TCF complex downstream genes.